ADAP Earnings & Forecasts - Benzinga

SPY764.41+0.05%QQQ742.65+0.08%BTC/USD84,802.93+1.49%DIA508.86+0.04%GLD382.75−0.00%TLT77.70−0.02%

ADAP

ADAPNasdaq Private Market

Private market price is not available

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

ADAP Earnings & Forecasts - Benzinga

ADAP Earnings & Forecasts

ADAP (ADAP) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

ADAP Guidance

Recent Earnings Results

Metric	Q2 '25	Q1 '25	Q4 '24	Q3 '24
Earnings Per Share (Non-GAAP)
Estimate	$-0.14	$-0.17	$-0.15	$-0.13
Actual	$-0.02	$-0.03	$-0.30	$-0.07
Surprise	+85.7%	+82.3%	-100.0%	+46.2%
Revenue
Estimate	$7.9M	$6.5M	$8.4M	$11.2M
Actual	$13.7M	$7.3M	$3.2M	$40.9M
Surprise	+72.2%	+11.2%	-61.7%	+266.2%

Earnings & Guidance News

Dow Jumps Over 200 Points; Cleveland-Cliffs Shares Jump After Q3 Results

Avi Kapoor

PRO
Adaptimmune Therapeutics Q2 EPS $(0.02) Beats $(0.08) Estimate, Sales $13.677M Beat $9.914M Estimate

Adaptimmune Therapeutics (NASDAQ:ADAP) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.08) by 76.19 percent. This is a 150 percent decrease over earnings of $0.04 per share

Benzinga Newsdesk

Crude Oil Gains 2%; CEA Industries Shares Spike Higher

Avi Kapoor

US Stocks Mixed; Enterprise Products Partners Posts Upbeat Earnings

Avi Kapoor

PRO
Adaptimmune Therapeutics Q1 EPS $(0.03) Beats $(0.12) Estimate, Sales $7.29M Beat $6.17M Estimate

Adaptimmune Therapeutics (NASDAQ:ADAP) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.12) by 75 percent. This is unchanged from the same period last year. The company

Benzinga Newsdesk

Earnings Scheduled For May 13, 2025

Benzinga Insights

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q2	Aug 13, 2025	$-0.02	$-0.14	85.7 %
Q1	May 13, 2025	$-0.03	$-0.17	82.3 %
Q4	Mar 20, 2025	$-0.30	$-0.15	-100.0 %
Q3	Nov 13, 2024	$-0.07	$-0.13	46.2 %

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q2	Aug 13, 2025	$13.68M	$7.94M	72.2 %
Q1	May 13, 2025	$7.29M	$6.55M	11.2 %
Q4	Mar 20, 2025	$3.22M	$8.42M	-61.7 %
Q3	Nov 13, 2024	$40.90M	$11.17M	266.2 %